Amerise Biosciences opened higher at ₹0.87, compared with its previous close of ₹0.85. In the last trading session on 12 Nov 2026, the stock traded between ₹0.82 and ₹0.87, with an average traded price of ₹0.85. It showed a downward intraday trend.
An investment of ₹10,000 made 5 years ago in Amerise Biosciences is now worth
₹ 5,287.00
Resulting in a loss of
₹ 4,713.00 (47.13%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-0.02 (-2.35%)
Day High
₹0.87
Day Low
₹0.82
Day Open
₹0.87
Prev Close
₹0.85
Volume
25,610
Value Traded
₹0.00 Cr
1W Return
-1.19%
1M Return
3.75%
3M Return
-3.49%
6M Return
7.79%
1Y Return
36.07%
Market Cap (₹ Cr.)
5
PE Ratio
-85.00
PB Ratio
1.07
Dividend Yield
-
ROE
0.30%
ROCE
0.39%
Book Value (₹)
0.80
Face Value (₹)
1.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-1.19%
6 Weeks
-
1 Month
3.75%
3 Months
-3.49%
9 Months
18.57%
No data available.
Amerise Biosciences Q2FY27 Results: Zero revenue, net loss widens to ₹5.76 lakh
Amerise Biosciences reported zero revenue from operations for Q2FY27. Net loss for the quarter widened to ₹5.76 lakh from ₹4.23 lakh in Q2FY26. Cash and cash equivalents dropped sharply to ₹2.46 lakh from ₹59.19 lakh. Half-year net loss stood at ₹13.91 lakh, driven by employee and administrative expenses.
13 days agoSnehjeev Ventures crosses 13% stake in Amerise Biosciences
Snehjeev Ventures crossed 13% holding in Amerise Biosciences on October 28, 2026. Acquired 18,342 equity shares via open market purchase. Total stake rose from 12.99% to 13.02%. Acquirer is not part of the promoter group.
13 days agoAmerise Biosciences shareholders approve FY26 accounts, appoint Hines as CFO
Amerise Biosciences approved FY26 financial statements and CFO appointment at 41st AGM. Albert Hines appointed as Wholetime Director and CFO with unanimous shareholder approval. Voting turnout was 19.19% with zero votes cast against either resolution. Only 38 out of 33,533 registered shareholders participated in the voting process.
1mo agoAmerise Biosciences sets Sept 17-24 book closure for AGM
Book closure runs from September 17 to September 24, 2026. AGM is scheduled for September 24, 2026. E-voting opens on September 21 and closes on September 23. Cut-off date for voting eligibility is September 17, 2026.
2mo agoAmerise Biosciences Q1 Results: Net Loss Widens to ₹8.14 Lakh
Amerise Biosciences Ltd reported a net loss of ₹8.14 lakh for Q1FY27, driven by nil revenue and a sharp rise in other expenses to ₹7.21 lakh. This contrasts with a profit of ₹6.13 lakh in the previous quarter. Statutory auditors Bipin & Co. reviewed the results.
3mo agoSnehjeev Ventures crosses 9% stake in Amerise Biosciences
Snehjeev Ventures Pvt Ltd and its PACs crossed the 9% holding threshold in Amerise Biosciences Ltd on July 20, 2026, by acquiring 28,000 shares in the open market. The group's total stake is now 9.02%. The disclosure was filed with BSE Limited on July 29, 2026, under SEBI SAST regulations.
3mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹4,420.80 | +3.82% | ₹1,22,544.58 | 52.10 | +0.58% | |
| ₹8,088.50 | +0.10% | ₹1,21,886.89 | 37.90 | +5.32% | |
| ₹2,247.50 | +0.98% | ₹62,403.73 | 47.30 | +25.11% | |
| ₹2,226.90 | +3.29% | ₹58,743.54 | 24.00 | +143.70% | |
| ₹3,327.00 | -0.39% | ₹42,261.84 | 37.50 | -15.00% | |
| ₹4,145.10 | +0.23% | ₹39,627.40 | 37.50 | +1.77% | |
| ₹24,155.00 | +0.23% | ₹38,279.03 | 303.70 | +37.82% | |
| ₹1,308.80 | -0.39% | ₹36,532.78 | 26.80 | +51.54% | |
| ₹1,279.00 | +0.43% | ₹34,360.36 | 60.80 | -19.32% | |
| ₹3,165.00 | -1.27% | ₹29,535.90 | 24.20 | -12.16% | |
| ₹1,672.80 | +2.11% | ₹24,342.56 | 47.10 | +58.01% | |
| ₹3,123.90 | +0.87% | ₹23,497.58 | 51.40 | +1.50% |
An investment of ₹10,000 made 5 years ago in Amerise Biosciences is now worth
₹ 5,287.00
Resulting in a loss of
₹ 4,713.00 (47.13%)
Note: Past profits do not guarantee future returns.
